Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2017 1
2018 2
2019 2
2020 4
2021 9
2022 10
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Metronomic Chemotherapy for Metastatic Breast Cancer.
Krajnak S, Battista MJ, Hasenburg A, Schmidt M. Krajnak S, et al. Oncol Res Treat. 2022;45(1-2):12-17. doi: 10.1159/000520236. Epub 2021 Nov 18. Oncol Res Treat. 2022. PMID: 34794154 Free article. Review.
Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer.
Almstedt K, Heimes AS, Kappenberg F, Battista MJ, Lehr HA, Krajnak S, Lebrecht A, Gehrmann M, Stewen K, Brenner W, Weikel W, Rahnenführer J, Hengstler JG, Hasenburg A, Schmidt M. Almstedt K, et al. Among authors: krajnak s. Eur J Cancer. 2022 Sep;173:10-19. doi: 10.1016/j.ejca.2022.06.012. Epub 2022 Jul 12. Eur J Cancer. 2022. PMID: 35839597
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer.
Heimes AS, Almstedt K, Krajnak S, Runkel A, Droste A, Schwab R, Stewen K, Lebrecht A, Battista MJ, Brenner W, Hasenburg A, Gehrmann M, Hengstler JG, Schmidt M. Heimes AS, et al. Among authors: krajnak s. Biomedicines. 2022 Oct 21;10(10):2656. doi: 10.3390/biomedicines10102656. Biomedicines. 2022. PMID: 36289918 Free PMC article.
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer.
Almstedt K, Mendoza S, Otto M, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Gerhold-Ay A, Hasenburg A, Denkert C, Schmidt M. Almstedt K, et al. Among authors: krajnak s. Breast Cancer Res Treat. 2020 Jul;182(1):137-146. doi: 10.1007/s10549-020-05688-1. Epub 2020 May 20. Breast Cancer Res Treat. 2020. PMID: 32436145 Free PMC article.
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer.
Schmidt M, Edlund K, Hengstler JG, Heimes AS, Almstedt K, Lebrecht A, Krajnak S, Battista MJ, Brenner W, Hasenburg A, Rahnenführer J, Gehrmann M, Kellokumpu-Lehtinen PL, Wirtz RM, Joensuu H. Schmidt M, et al. Among authors: krajnak s. Cancers (Basel). 2021 Jul 20;13(14):3626. doi: 10.3390/cancers13143626. Cancers (Basel). 2021. PMID: 34298839 Free PMC article.
28 results